International Institute for Advanced Pharmaceutical Manufacturing






The International Institute for Advanced Pharmaceutical Manufacturing brings together world-leading academic expertise to deliver new end-to-end continuous manufacturing capabilities that will transform the global supply chain for medicines.



Founded by the EPSRC Future Continuous Manufacturing and Advanced Crystallisation (CMAC) Hub (UK), the Centre for Structured Organic Particulate Systems (C-SOPS, US) and the Research Center Pharmaceutical Engineering, (RCPE, Austria), the joint programme leverages existing extensive investments in the UK, US and EU by creating a vibrant international manufacturing research community that will accelerate progress through excellence in research. Furthermore, by engaging with regulators the research will be targeted to maximise impact for end users.










I2APM is a research and educational partnership, with the goal of advancing the science and technology of integrated primary and secondary continuous manufacturing of pharmaceutical products.


The Institute will also build on intellectual expertise among partner institutions that will enable collaborations to advance the paradigm of end-to-end closed-loop control for continuous manufacturing of pharmaceutical products.

Find out more about our people here.